In the last year, some drugmakers have pulled back from the sector, including Pfizer, which recently stopped selling its gene ...
An indigenously developed CAR T-cell gene therapy has achieved a 73% response rate for certain blood cancers in India. The ...
Evolution in women's cancer diagnostics: from histopathology to molecular testing, personalized treatment for breast, ovarian ...
Yale scientists have discovered a promising way to trigger immune responses against certain tumors, using a lupus-related ...
But often the cancer will return and the entire bladder will be removed. “That comes like all kind of the side effects a ...
People with inflammatory bowel disease (IBD) also have an increased risk of developing colorectal cancer. However, the exact ...
Researchers are conducting a groundbreaking trial that could revolutionize the way the body fights cancer, particularly for ...
1d
GlobalData on MSNFDA aligns with Imunon’s Phase III trial protocol for ovarian cancer treatmentImunon is initiating sites for the trial and collaborating with investigators to commence participant enrolment.
19h
News-Medical.Net on MSNNew insights into therapy resistance in breast cancerA new review was published in , Volume 16, on March 13, 2025, titled "Signaling pathway dysregulation in breast cancer." ...
CRISPR technique can target single genes essential for cancer cell survival, toppling the whole structure, says nanomedicine ...
A new study published in The Lancet Haematology journal says that an indigenously developed gene therapy for certain blood ...
23h
Clinical Trials Arena on MSNRactigen’s RAG-01 shows potential in treating non-muscle invasive bladder cancerThe company’s Phase I trial found that patients remained disease free after three months utilising the lowest doses of RAG-01 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results